Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s400986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Xuehui Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanchang University, Nanchang, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gastrointestinal Stromal Tumors, ATP Binding Cassette Transporter, Subfamily G, Member 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nanchang University, Nanchang, People's Republic of China.
- Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
- Jiangxi Provincial Drug Inspector Center, Jiangxi Provincial Drug Administration, Nanchang, People's Republic of China.
- Department of Pharmacy, Linyi Central Hospital, Linyi, People's Republic of China.
ORCID-Profile: Xuehui Jiang
Zitieren
APA
Jiang, X., Fu, Q., Jing, Y., Kong, Y., Liu, H., Peng, H., Rexiti, K., & Wei, X. (2023). Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s400986
Vancouver
Jiang X, Fu Q, Jing Y, Kong Y, Liu H, Peng H, et al. Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s400986
BibTeX
@article{Jiang2023,
author = {Jiang, Xuehui and Fu, Qun and Jing, Yan and Kong, Ying and Liu, Hong and Peng, Hongwei and Rexiti, Kaisaner and Wei, Xiaohua},
title = {Personalized Dose of Adjuvant Imatinib in Patients with Gastrointestinal Stromal Tumors: Results from a Population Pharmacokinetic Analysis},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s400986}
}
EUVIMED